EN DE

Harte Hanks, Inc (HHS) Fair Value & Analysis

Industrials · US · Market cap $17.8M

HH Harte Hanks, Inc logo Harte Hanks, Inc HHS · US
Price$2.28
Fair Value$1.85
Upside-18.9%
Quality53/100
Watch Harte Hanks, Inc for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Loss-making · -0.7% net margin
Low debt · negative free cash flow
Trails peers (4/12)
Narrow moat 13/100
Evidence: Medium Range $1.38 – $2.77 Share as image

Fair value as of: Jul 26, 2026

From 4 valuation models · updated 16 days ago

A solid business, but screening 19% overvalued on our models.

What matters now

  • Solid but not exceptional quality (53/100) and above fair value, neither a clear bargain nor a standout compounder.
  • A fairly wide model range ($1.38 to $2.77) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

$17.65 $2.07 Fair Value $1.85 Apr 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 26, 2026.

How to read this chart

60‑month range $2.07 – $17.65 · fair‑value band $1.38 – $2.77 · the $2.28 price screens above the $1.85 fair value. Dashed = 300-day average. As of Jul 26, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Harte Hanks, Inc (HHS) currently trades at $2.28, while our model-based Fair Value estimate is $1.85, implying the stock looks roughly 18.9% overvalued today. The Quality Score stands at 53/100 (solid quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Harte Hanks, Inc generated revenue of $155M at a net margin of -0.7%. Revenue declined 10.3% year over year. It earns a return on equity of -5.0%. Net debt stands at $16.8M. Fundamentals as of Jul 26, 2026

Our scenario range runs from $1.38 (bear case) to $2.77 (bull case); at $2.28, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 58% below its 52-week high and 3% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -14% fair-value upside, at -19%, HHS screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Gordon GGM $4.22 $4.52 $4.94 70
DDM Multi-Stage $4.22 $4.89 $5.72 61
NCAV (Graham) $1.38 $1.85 $2.77 50
All 4 models by family
DCF Models
Owner Earnings $0.9600 $1.19 $1.56 31
Dividend Discount
Gordon GGM $4.22 $4.52 $4.94 70
DDM Multi-Stage $4.22 $4.89 $5.72 61
Asset-Based
NCAV (Graham) $1.38 $1.85 $2.77 50

Widest divergence: Dividend Discount ($4.52) versus DCF Models ($1.19). Highest evidence: Gordon GGM (70).

Notify me when HHS reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) $155M
Revenue growth (YoY) -10.3%
Net margin -0.7%
Return on equity -5.0%
Free cash flow −$4.5M FY2025
Operating margin -2.4%
More key figures
EPS (TTM) $-0.1400
EPS growth (YoY) -90.3%
Net debt $16.8M FY2025

Figures from reported company fundamentals · as of Jul 26, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 53/100

Of which business quality 55 · Market factors (momentum, volatility) 22

Profitability 46
Margins and returns on capital today
Quality Growth 32
Are margins and returns improving?
Cashflow 40
Earnings quality: real cash, not paper profit
Fin. Strength 59
Balance sheet, leverage, solvency risk
Investment 95
Disciplined investing over empire-building
Low Volatility 56
Calm price path (market factor)
Momentum 12
Price trend over the last 3–12 months (market factor)
52W Momentum 1
Distance to the 52-week high (market factor)
Net Issuance 75
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Revenue Solutions, Customer Care, and Fulfillment and Logistics.

Full company description

Harte Hanks, Inc. operates as a customer experience company in the United States and internationally. It operates through three segments: Revenue Solutions, Customer Care, and Fulfillment and Logistics. It offers data and analytics, including audience identification, profiling, segmentation and prioritization, and predictive modeling and data strategy; research and intelligence, helps in understanding of customers, category, competitors, and capabilities; strategy, which plans and executes omnichannel marketing, demand generation, and customer experience programs; creative and content, including creative concepts, messaging and content assets for print, broadcast, direct mail, website, app, display, social, mobile, search engine marketing, and voice; marketing technology, a website and app development, e-commerce development and enablement, database building and management, platform architecture creation, and marketing automation; digital and multi-channel marketing execution and advertising; demand generation and account based marketing; and managed marketing services. It also provides product, print-on-demand, and mail fulfillment services, including as printing on demand and distributing literature, managing product recalls, and promotional and branded product distribution; and third-party logistics and freight optimization services. In addition, the company offers inside sales outsourcing, which provides B2B enterprises, and small to midsized businesses with an outsourced sales service; lead generation services; and sales play development, as well as customer service outsourcing, customer care technology and artificial intelligence transformation, and self-service technology. It serves B2B, healthcare, pharmaceuticals, health insurance, consumer, travel, hospitality, streaming, entertainment, quick service restaurants, financial, fintech, automotive, and retail industries. The company was founded in 1923 and is headquartered in Chelmsford, Massachusetts.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Harte Hanks, Inc reported revenue of $160M in FY2025 versus $195M in FY2021, a compound −4.8%/yr. Reported net income was −$811K in FY2025.

Growth Quality 55/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$160M
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−1.6%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−3.2%
Avg. growth/yr (32Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−2.5%
Revenue −4.8%/yr
FY21 $195M
FY22 $206M
FY23 $191M
FY24 $185M
FY25 $160M
Net income
FY21 $15.0M
FY22 $36.8M
FY23 −$1.6M
FY24 −$30.3M
FY25 −$811K

HHS screens 19% overvalued. Compare with CITIC Limited →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Harte Hanks, Inc Fair Value". https://www.fairvalue-calculator.com/stock/HHS

Peer Group

Conglomerates · 369 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 53 · Above median
Fair Value upside −19% · Below median
Return on assets -0% · Bottom 25%
Net margin (TTM) -1% · Bottom 25%
Operating margin (TTM) -2% · Bottom 25%
Revenue growth -10% · Bottom 25%
Debt / equity 0.24× · Higher than median

Valuation Multiples vs Conglomerates median · lower = cheaper

P/B 0.87× · Pricier than median
P/S (TTM) 0.12× · Cheaper than 75% of peers
EV/EBITDA 4.2× · Cheaper than median
PEG 1.19× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 8 · sector 20
FUTURE 0 · sector 16
PAST 0 · sector 20
HEALTH 88 · sector 88
DIVIDEND 0 · sector 39

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate (as of Jul 26, 2026).

Stock Price Fair Value vs Fair Value
CITIC Limited 0267 HK$11.28 HK$22.56 +100%
SK Inc 034730 580,000 KRW 497,919 KRW -14%
PT Astra International Tbk, ASII 4,810 IDR 9,620 IDR +100%
The Siam Cement Public Company SCC 254.00 THB 199.40 THB -21%
SRF Limited SRF ₹2,875 ₹1,053 -63%
Empresas Copec S.A COPEC 6,330 CLP 10,879 CLP +72%
Posco International Corporation 047050 50,900 KRW 61,248 KRW +20%
Tube Investments of India Limited TIINDIA ₹2,940 ₹559.30 -81%
Doosan Corporation 000155 464,000 KRW 75,620 KRW -84%
Thermax Limited THERMAX ₹4,809 ₹1,087 -77%

Compare Harte Hanks, Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Harte Hanks, Inc (HHS) overvalued or undervalued?
As of Jul 26, 2026, our model estimates a fair value of $1.85 versus a price of $2.28, about −19% (overvalued).
What is the fair value of HHS?
Our model-based fair value for Harte Hanks, Inc is $1.85 (as of Jul 26, 2026), built from audited fundamentals. The current price is $2.28.
What is the quality score of HHS?
Harte Hanks, Inc has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Harte Hanks, Inc (HHS)?
Harte Hanks, Inc reported trailing-twelve-month revenue of about $155M (latest available figure, as of Jul 26, 2026).
What is the net profit margin of HHS?
The net profit margin of Harte Hanks, Inc is about -0.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Harte Hanks, Inc and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.